Last €73.78 EUR
Change Today +0.21 / 0.29%
Volume 364.8K
As of 11:35 AM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

essilor international (EI) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/6/13 - €89.09
52 Week Low
03/14/14 - €70.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ESSILOR INTERNATIONAL (EI)

Related News

No related news articles were found.

essilor international (EI) Related Businessweek News

No Related Businessweek News Found

essilor international (EI) Details

Essilor International SA designs, manufactures, and sells ophthalmic lenses and ophthalmic optical instruments in North America, Europe, the Asia Pacific, Africa, the Middle East, and Latin America. It offers products for correcting myopia, hypermetropia, astigmatism, and presbyopia. The company operates through three segments: Lenses and Optical Instruments, Equipments, and Readers. The Lenses and Optical Instruments segment offers Varilux range of progressive lenses; Crizal range of lenses with anti-reflective, anti-smudge, and anti-static lenses; Optifog for anti-fog lenses; Xperio for polarized lenses; and Nikon, Transitions, Kodak, and Polaroid photochromic lenses. This segment also designs, develops, distributes, and maintains a range of optical instruments for opticians and prescription laboratories; and vision screening instruments for eye-care professionals, schools, occupational medicine centers, the military, and other institutions. The Equipments segment engages manufactures and sells equipment and consumables, such as digital surfacing machines and anti-reflective lenses for prescription laboratories, and integrated optical chains and lens manufacturers. The Readers segment designs and markets non-prescription reading glasses and sunglasses under the eyewear brands, such as Foster Grant, Sight Station, Magnivision, and Bolon, as well as licenses for brands comprising Ironman, Body Glove, Disney, Field & Stream, Dockers, Reebok, and Nine West. It has a network of 454 prescription laboratories and edging centers, as well as various research and development centers. The company was founded in 1972 and is headquartered in Charenton-le-Pont, France.

55,129 Employees
Last Reported Date: 03/25/14
Founded in 1972

essilor international (EI) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: €1.6M
Compensation as of Fiscal Year 2013.

essilor international (EI) Key Developments

Essilor International Approves Amendments to Articles of Association

Essilor International SA at the annual general meeting held on May 7, 2014 approved amendment of Article 14 of the Articles to modify the duration of the directors' term of office and amendment of Article 12 of the Articles to set the appointment rules for directors representing employees in accordance with the provisions of the Law of 14 June 2013 on employment protection.

Essilor International SA Recommends Increased Dividend for 2013, Payable on 27 May 2014

Essilor International SA recommended increasing the dividend by 6.8% to EUR 0.94 per share for 2013. The dividend will be paid from 27 May 2014.

Essilor International SA - Shareholder/Analyst Call

2014 Annual Shareholders' Meeting


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EI:FP €73.78 EUR +0.21

EI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hoya Corp ¥3,381 JPY -16.50
Luxottica Group SpA €42.64 EUR +0.17
Safilo Group SpA €15.72 EUR +0.10
View Industry Companies

Industry Analysis


Industry Average

Valuation EI Industry Range
Price/Earnings 25.8x
Price/Sales 3.0x
Price/Book 4.0x
Price/Cash Flow 26.0x
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESSILOR INTERNATIONAL, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at